Key result
Repeat carotid replacement plus radiotherapy maintains recurrence-free local control for ~2 years in recurrent liposarcoma.
Why the study?
Dedifferentiated liposarcoma is prone to local recurrence and complete resection remains the treatment of choice, but management of recurrent cases involving carotid artery replacement is not well established.
Case Report (n=1)
No
Repeat vascular graft replacement for the carotid artery may be a feasible and effective local control strategy for selected patients with recurrent dedifferentiated liposarcoma invading major cervical vessels.
May support repeat carotid reconstruction in select recurrent liposarcoma cases; leaves open broader applicability and prospective validation.
Dedifferentiated liposarcoma is prone to local recurrence, and complete resection remains the treatment of choice. We report a 70-year-old man who underwent carotid artery replacement with vascular grafts on two occasions for recurrent disease. A recurrent tumor invading the right common carotid and subclavian arteries was resected with vascular graft replacement. After 2 years and 7 months, recurrence developed around the carotid artery anastomosis. En bloc tumor resection with repeat carotid artery replacement using a prosthetic vascular graft was successfully performed. The patient was discharged on postoperative Day 9 without postoperative neurological deficits. Postoperative radiotherapy was administered following both operations. He remains free of recurrence more than 2 years after the most recent surgery. This case suggests that repeat carotid artery replacement using a vascular graft may be a feasible treatment option for selected patients with recurrent dedifferentiated liposarcoma.
No takes yet. Share an insight, caveat, or question.
Tamura et al. (2026) conducted a case report in Recurrent dedifferentiated liposarcoma (n=1). Repeat carotid artery replacement using a vascular graft was evaluated. Repeat carotid artery replacement using a vascular graft and radiotherapy provided effective local control without recurrence for over 2 years in a patient with recurrent liposarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: